Global Non-Invasive Blood Glucose Monitoring System Market Research Report 2024

Publication ID:

PB507249091

Publication Date:

July 25, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Non-Invasive Blood Glucose Monitoring System market was valued at US$ 20 million in 2023 and is anticipated to reach US$ 83 million by 2030, witnessing a CAGR of 8.5% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Non-Invasive Blood Glucose Monitoring System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Blood Glucose Monitoring System.
Report Scope
The Non-Invasive Blood Glucose Monitoring System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Invasive Blood Glucose Monitoring System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Invasive Blood Glucose Monitoring System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Medtronic plc
F. Hoffmann-La Roche Ltd.
Ascensia Diabetes Care
Dexcom, Inc.
Sanofi Novo Nordisk
Insulet Corporation
Ypsomed Holdings
Glysens Incorporated
Segment by Type
Wearable Blood Glucose Monitoring Systems
Non-wearable /Table-top Blood Glucose Monitoring Systems
Segment by Application
Hospitals
Homecare
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-Invasive Blood Glucose Monitoring System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-Invasive Blood Glucose Monitoring System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Non-Invasive Blood Glucose Monitoring System Market Overview
1.1 Product Overview and Scope of Non-Invasive Blood Glucose Monitoring System
1.2 Non-Invasive Blood Glucose Monitoring System Segment by Type
1.2.1 Global Non-Invasive Blood Glucose Monitoring System Market Value Comparison by Type (2024-2030)
1.2.2 Wearable Blood Glucose Monitoring Systems
1.2.3 Non-wearable /Table-top Blood Glucose Monitoring Systems
1.3 Non-Invasive Blood Glucose Monitoring System Segment by Application
1.3.1 Global Non-Invasive Blood Glucose Monitoring System Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Clinics
1.4 Global Non-Invasive Blood Glucose Monitoring System Market Size Estimates and Forecasts
1.4.1 Global Non-Invasive Blood Glucose Monitoring System Revenue 2019-2030
1.4.2 Global Non-Invasive Blood Glucose Monitoring System Sales 2019-2030
1.4.3 Global Non-Invasive Blood Glucose Monitoring System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Non-Invasive Blood Glucose Monitoring System Market Competition by Manufacturers
2.1 Global Non-Invasive Blood Glucose Monitoring System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Non-Invasive Blood Glucose Monitoring System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Non-Invasive Blood Glucose Monitoring System Average Price by Manufacturers (2019-2024)
2.4 Global Non-Invasive Blood Glucose Monitoring System Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-Invasive Blood Glucose Monitoring System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Invasive Blood Glucose Monitoring System, Product Type & Application
2.7 Non-Invasive Blood Glucose Monitoring System Market Competitive Situation and Trends
2.7.1 Non-Invasive Blood Glucose Monitoring System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-Invasive Blood Glucose Monitoring System Players Market Share by Revenue
2.7.3 Global Non-Invasive Blood Glucose Monitoring System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-Invasive Blood Glucose Monitoring System Retrospective Market Scenario by Region
3.1 Global Non-Invasive Blood Glucose Monitoring System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Non-Invasive Blood Glucose Monitoring System Global Non-Invasive Blood Glucose Monitoring System Sales by Region: 2019-2030
3.2.1 Global Non-Invasive Blood Glucose Monitoring System Sales by Region: 2019-2024
3.2.2 Global Non-Invasive Blood Glucose Monitoring System Sales by Region: 2025-2030
3.3 Global Non-Invasive Blood Glucose Monitoring System Global Non-Invasive Blood Glucose Monitoring System Revenue by Region: 2019-2030
3.3.1 Global Non-Invasive Blood Glucose Monitoring System Revenue by Region: 2019-2024
3.3.2 Global Non-Invasive Blood Glucose Monitoring System Revenue by Region: 2025-2030
3.4 North America Non-Invasive Blood Glucose Monitoring System Market Facts & Figures by Country
3.4.1 North America Non-Invasive Blood Glucose Monitoring System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Non-Invasive Blood Glucose Monitoring System Sales by Country (2019-2030)
3.4.3 North America Non-Invasive Blood Glucose Monitoring System Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-Invasive Blood Glucose Monitoring System Market Facts & Figures by Country
3.5.1 Europe Non-Invasive Blood Glucose Monitoring System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Non-Invasive Blood Glucose Monitoring System Sales by Country (2019-2030)
3.5.3 Europe Non-Invasive Blood Glucose Monitoring System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Invasive Blood Glucose Monitoring System Market Facts & Figures by Country
3.6.1 Asia Pacific Non-Invasive Blood Glucose Monitoring System Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Non-Invasive Blood Glucose Monitoring System Sales by Country (2019-2030)
3.6.3 Asia Pacific Non-Invasive Blood Glucose Monitoring System Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-Invasive Blood Glucose Monitoring System Market Facts & Figures by Country
3.7.1 Latin America Non-Invasive Blood Glucose Monitoring System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Non-Invasive Blood Glucose Monitoring System Sales by Country (2019-2030)
3.7.3 Latin America Non-Invasive Blood Glucose Monitoring System Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-Invasive Blood Glucose Monitoring System Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-Invasive Blood Glucose Monitoring System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Non-Invasive Blood Glucose Monitoring System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Non-Invasive Blood Glucose Monitoring System Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-Invasive Blood Glucose Monitoring System Sales by Type (2019-2030)
4.1.1 Global Non-Invasive Blood Glucose Monitoring System Sales by Type (2019-2024)
4.1.2 Global Non-Invasive Blood Glucose Monitoring System Sales by Type (2025-2030)
4.1.3 Global Non-Invasive Blood Glucose Monitoring System Sales Market Share by Type (2019-2030)
4.2 Global Non-Invasive Blood Glucose Monitoring System Revenue by Type (2019-2030)
4.2.1 Global Non-Invasive Blood Glucose Monitoring System Revenue by Type (2019-2024)
4.2.2 Global Non-Invasive Blood Glucose Monitoring System Revenue by Type (2025-2030)
4.2.3 Global Non-Invasive Blood Glucose Monitoring System Revenue Market Share by Type (2019-2030)
4.3 Global Non-Invasive Blood Glucose Monitoring System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Non-Invasive Blood Glucose Monitoring System Sales by Application (2019-2030)
5.1.1 Global Non-Invasive Blood Glucose Monitoring System Sales by Application (2019-2024)
5.1.2 Global Non-Invasive Blood Glucose Monitoring System Sales by Application (2025-2030)
5.1.3 Global Non-Invasive Blood Glucose Monitoring System Sales Market Share by Application (2019-2030)
5.2 Global Non-Invasive Blood Glucose Monitoring System Revenue by Application (2019-2030)
5.2.1 Global Non-Invasive Blood Glucose Monitoring System Revenue by Application (2019-2024)
5.2.2 Global Non-Invasive Blood Glucose Monitoring System Revenue by Application (2025-2030)
5.2.3 Global Non-Invasive Blood Glucose Monitoring System Revenue Market Share by Application (2019-2030)
5.3 Global Non-Invasive Blood Glucose Monitoring System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Laboratories Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Medtronic plc
6.2.1 Medtronic plc Corporation Information
6.2.2 Medtronic plc Description and Business Overview
6.2.3 Medtronic plc Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic plc Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.2.5 Medtronic plc Recent Developments/Updates
6.3 F. Hoffmann-La Roche Ltd.
6.3.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.3.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.3.3 F. Hoffmann-La Roche Ltd. Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 F. Hoffmann-La Roche Ltd. Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.3.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.4 Ascensia Diabetes Care
6.4.1 Ascensia Diabetes Care Corporation Information
6.4.2 Ascensia Diabetes Care Description and Business Overview
6.4.3 Ascensia Diabetes Care Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ascensia Diabetes Care Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.4.5 Ascensia Diabetes Care Recent Developments/Updates
6.5 Dexcom, Inc.
6.5.1 Dexcom, Inc. Corporation Information
6.5.2 Dexcom, Inc. Description and Business Overview
6.5.3 Dexcom, Inc. Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dexcom, Inc. Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.5.5 Dexcom, Inc. Recent Developments/Updates
6.6 Sanofi Novo Nordisk
6.6.1 Sanofi Novo Nordisk Corporation Information
6.6.2 Sanofi Novo Nordisk Description and Business Overview
6.6.3 Sanofi Novo Nordisk Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sanofi Novo Nordisk Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.6.5 Sanofi Novo Nordisk Recent Developments/Updates
6.7 Insulet Corporation
6.6.1 Insulet Corporation Corporation Information
6.6.2 Insulet Corporation Description and Business Overview
6.6.3 Insulet Corporation Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Insulet Corporation Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.7.5 Insulet Corporation Recent Developments/Updates
6.8 Ypsomed Holdings
6.8.1 Ypsomed Holdings Corporation Information
6.8.2 Ypsomed Holdings Description and Business Overview
6.8.3 Ypsomed Holdings Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ypsomed Holdings Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.8.5 Ypsomed Holdings Recent Developments/Updates
6.9 Glysens Incorporated
6.9.1 Glysens Incorporated Corporation Information
6.9.2 Glysens Incorporated Description and Business Overview
6.9.3 Glysens Incorporated Non-Invasive Blood Glucose Monitoring System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Glysens Incorporated Non-Invasive Blood Glucose Monitoring System Product Portfolio
6.9.5 Glysens Incorporated Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Invasive Blood Glucose Monitoring System Industry Chain Analysis
7.2 Non-Invasive Blood Glucose Monitoring System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Invasive Blood Glucose Monitoring System Production Mode & Process
7.4 Non-Invasive Blood Glucose Monitoring System Sales and Marketing
7.4.1 Non-Invasive Blood Glucose Monitoring System Sales Channels
7.4.2 Non-Invasive Blood Glucose Monitoring System Distributors
7.5 Non-Invasive Blood Glucose Monitoring System Customers
8 Non-Invasive Blood Glucose Monitoring System Market Dynamics
8.1 Non-Invasive Blood Glucose Monitoring System Industry Trends
8.2 Non-Invasive Blood Glucose Monitoring System Market Drivers
8.3 Non-Invasive Blood Glucose Monitoring System Market Challenges
8.4 Non-Invasive Blood Glucose Monitoring System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Abbott Laboratories
Medtronic plc
F. Hoffmann-La Roche Ltd.
Ascensia Diabetes Care
Dexcom, Inc.
Sanofi Novo Nordisk
Insulet Corporation
Ypsomed Holdings
Glysens Incorporated

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂